Investors

Media

Welcome to the new Regeneron Newsroom. This newsroom is designed to provide members of the media with easy access to up-to-date information about the Company.

For an e-mail response to questions about Regeneron, please contact us at media@regeneron.com.



View all releases Recent Press Releases

Aug 4, 2015 Regeneron Reports Second Quarter 2015 Financial and Operating Results
Jul 28, 2015 Regeneron and Sanofi Launch Major New Immuno-Oncology Collaboration
Jul 24, 2015 Regeneron and Sanofi Announce FDA Approval of Praluent® (alirocumab) Injection, the First PCSK9 Inhibitor in the U.S., for the Treatment of High LDL Cholesterol in Adult Patients
Jul 24, 2015 Regeneron and Sanofi Announce CHMP Recommends European Approval of Praluent® (alirocumab) for the Treatment of Hypercholesterolemia
Jul 8, 2015 Regeneron and Sanofi Announce Phase 3 Results Showing LDL-C Reductions of More Than 60 Percent in Japanese Patients Treated with Praluent® (alirocumab) Injection
Jul 8, 2015 Regeneron to Report Second Quarter 2015 Financial and Operating Results and Host Conference Call and Webcast on August 4, 2015
Jun 30, 2015 New Film Documents Heart Felt Stories of People Living with High LDL Cholesterol
Jun 29, 2015 Regeneron Rapid Response Platform for Emerging Infectious Diseases Described in Proceedings of the National Academy of Sciences Publication
Jun 26, 2015 EYLEA® (aflibercept) Injection Receives Approval in Japan for the Treatment of Retinal Vein Occlusion
Jun 25, 2015 Regeneron Announces 2015 Winners of the Regeneron Prize for Creative Innovation


Close
Form content here please :)